An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

Alzheimer's disease (AD) is the most common neurodegenerative disease. Imbalance between the production and clearance of amyloid β (Aβ) peptides is considered to be the primary mechanism of AD pathogenesis. This amyloid hypothesis is supported by the recent success of the human anti‐amyloid ant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EMBO Mol Med
Egile Nagusiak: Cheng, Yu‐Sung, Chen, Zih‐ten, Liao, Tai‐Yan, Lin, Chen, Shen, Howard C‐H, Wang, Ya‐Han, Chang, Chi‐Wei, Liu, Ren‐Shyan, Chen, Rita P‐Y, Tu, Pang‐hsien
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412883/
https://ncbi.nlm.nih.gov/pubmed/28356312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606666
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak